NO961423L - Oligopeptider avledet fra C-reaktive proteinfragmenter - Google Patents

Oligopeptider avledet fra C-reaktive proteinfragmenter

Info

Publication number
NO961423L
NO961423L NO961423A NO961423A NO961423L NO 961423 L NO961423 L NO 961423L NO 961423 A NO961423 A NO 961423A NO 961423 A NO961423 A NO 961423A NO 961423 L NO961423 L NO 961423L
Authority
NO
Norway
Prior art keywords
group
amino acid
leucine
absent
acid residue
Prior art date
Application number
NO961423A
Other languages
English (en)
Norwegian (no)
Other versions
NO961423D0 (no
Inventor
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Massimo Pinori
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of NO961423D0 publication Critical patent/NO961423D0/no
Publication of NO961423L publication Critical patent/NO961423L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO961423A 1993-10-12 1996-04-11 Oligopeptider avledet fra C-reaktive proteinfragmenter NO961423L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments

Publications (2)

Publication Number Publication Date
NO961423D0 NO961423D0 (no) 1996-04-11
NO961423L true NO961423L (no) 1996-06-10

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961423A NO961423L (no) 1993-10-12 1996-04-11 Oligopeptider avledet fra C-reaktive proteinfragmenter

Country Status (19)

Country Link
US (1) US6057295A (de)
EP (1) EP0723552B1 (de)
JP (1) JP3221881B2 (de)
KR (1) KR100363408B1 (de)
CN (1) CN1041524C (de)
AT (1) ATE226591T1 (de)
AU (1) AU684511B2 (de)
CA (1) CA2173939C (de)
DE (1) DE69431603T2 (de)
DK (1) DK0723552T3 (de)
ES (1) ES2185652T3 (de)
FI (1) FI961584A0 (de)
HU (1) HUT75538A (de)
IL (1) IL109761A0 (de)
IT (1) IT1271486B (de)
NO (1) NO961423L (de)
PT (1) PT723552E (de)
WO (1) WO1995010531A1 (de)
ZA (1) ZA943610B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (de) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidinderivate zur Behandlung von Hepatitis C Virusinfektion
AU2009292643B2 (en) 2008-09-19 2016-02-18 Nektar Therapeutics Polymer conjugates of therapeutic peptides
JP5959440B2 (ja) 2010-01-19 2016-08-02 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 病原体の検出および治療のための改変オプソニン
AU2012284097B2 (en) 2011-07-18 2017-08-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
WO2014144325A1 (en) 2013-03-15 2014-09-18 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
WO2014190040A1 (en) 2013-05-21 2014-11-27 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3083658B1 (de) 2013-12-18 2019-05-08 President and Fellows of Harvard College Detektion gram-positiver bakterien mit crp
EP3763378A1 (de) 2015-08-06 2021-01-13 President and Fellows of Harvard College Verbesserte mikrobenbindende moleküle und verwendungen davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0253190B1 (de) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Teilweise retro-invertierte Analoge des Tuftsin, Methode zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
ZA943610B (en) 1995-01-25
DK0723552T3 (da) 2003-02-24
US6057295A (en) 2000-05-02
FI961584L (fi) 1996-04-11
PT723552E (pt) 2003-02-28
IL109761A0 (en) 1994-08-26
IT1271486B (it) 1997-05-28
HUT75538A (en) 1997-05-28
EP0723552A1 (de) 1996-07-31
HU9600934D0 (en) 1996-08-28
JPH09503200A (ja) 1997-03-31
AU684511B2 (en) 1997-12-18
CN1041524C (zh) 1999-01-06
NO961423D0 (no) 1996-04-11
DE69431603D1 (de) 2002-11-28
WO1995010531A1 (en) 1995-04-20
CN1133048A (zh) 1996-10-09
JP3221881B2 (ja) 2001-10-22
AU6844194A (en) 1995-05-04
ITMI932154A1 (it) 1995-04-12
FI961584A7 (fi) 1996-04-11
FI961584A0 (fi) 1996-04-11
EP0723552B1 (de) 2002-10-23
DE69431603T2 (de) 2003-03-13
ES2185652T3 (es) 2003-05-01
CA2173939C (en) 2002-08-27
ITMI932154A0 (it) 1993-10-12
ATE226591T1 (de) 2002-11-15
KR100363408B1 (ko) 2003-02-11
CA2173939A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
NO961423L (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
RU95112539A (ru) Новый полипептид и фармацевтическая композиция против вич-инфекции
KR840005080A (ko) 디노르핀 아미드 동족체의 제조방법
ES497696A0 (es) Procedimiento para la obtencion de acilpeptidos
NO834340L (no) Nye polypeptider
PH12022551543A1 (en) Mutant rsv f protein and use thereof
DK0479912T3 (da) Fremgangsmåde til hæmning af N-endereglens forløb i levende celler
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
KR970005043B1 (en) Tumor necrosis factor alpha muteins
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
MacKenzie et al. Gas chromatography—mass spectrometry of the N (O)-heptafluorobutyryl isobutyl esters of the protein amino acids using electron impact ionisation
DK39591A (da) Peptidforbindelser
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
EP1609861A4 (de) Ionenkanalaktivität hemmende niedrigmolekulare peptide
Lu et al. The primary structure of tubulin sequences of the carboxyl terminus and seven other cyanogen bromide peptides from the α-chain
ES403973A1 (es) Un procedimiento para la preparacion de monapeptidos.
DE3782880D1 (de) Hemmende peptide.
WO2003097678A3 (en) Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum
DE60104702D1 (de) Auftrennung von isomeren von n-[n-(3,3-dimethylbutyl)-l- alpha-aspartyl]-l-phenylalanin-1-methylester durch verwendung mittels metallischer ionen
HK1046693A1 (zh) 用於免疫治疗的修饰的肽和拟肽
KR840006328A (ko) 펩티드의 제조방법
MX2024007182A (es) Polipeptidos de penetracion celular (cpp) y su uso en terapia humana.
GB992957A (en) New decapeptides and their manufacture
JPS5225768A (en) Preparation of novel pentapeptides